Cervical lymphatic tissue as an alternative donor site for the microsurgical treatment of secondary lymphedema in limbs
Gilberto Vaz Teixeira, Felipe de Borba Chiaramonte Silva, Edgar Edinson Fernandez Altamiranda, Sofia Ratchitzki Teixeira, Gabriel Manfro
Abstract
Introduction: Lymphedema is characterized by the accumulation of lymph in the interstitial tissue, leading to limb deformities, mobility issues, infections, and reduced self-esteem, collectively reducing patients’ quality of life. Since 2016, the microsurgical transfer of vascularized lymphatic tissue from the neck as a donor site has emerged as a notable surgical treatment option. Objective: To describe cervical lymphnodes as an option for a donor area for the transfer of vascularized tissue in lymphedema surgeries. Methods: Five microsurgical procedures were performed to transfer vascularized lymphatic tissue from cervical stages Ib, III, or IV as the donor site. Patient outcomes were evaluated from 15 to 180 days postoperatively using metric assessments and photographic documentation. Results: In this study, complete improvement in the measures of certain parts of the affected limb was observed in two of the five patients (100% improvement). Two patients experienced an improvement of over 50%. One patient, lost to follow-up, showed no improvement. Conclusion: Lymphatic tissue from cervical levels appears to be a viable donor site for the surgical treatment of lymphedema in the limbs. This method may yield promising future outcomes, constituting a new area of practice for head and neck surgeons.
Keywords
References
1. Ashikaga T, Krag DN, Land SR, Julian TB, Anderson SJ, Brown AM, Skelly JM, Harlow SP, Weaver DL, Mamounas EP, Costantino JP, Wolmark N. Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection. J Surg Oncol. 2010;102(2):111-8. http://dx.doi.org/10.1002/jso.21535. PMid:20648579. Figure 8. Healing of the donor site of patient CLS in the late postoperative period. Abreu et al. Arch Head Neck Surg. 2023;52:e20230021.
2. Donker M, van Tienhoven G, Straver ME, Meijnen P, van de Velde CJ, Mansel RE, Cataliotti L, Westenberg AH, Klinkenbijl JH, Orzalesi L, Bouma WH, van der Mijle HC, Nieuwenhuijzen GA, Veltkamp SC, Slaets L, Duez NJ, de Graaf PW, van Dalen T, Marinelli A, Rijna H, Snoj M, Bundred NJ, Merkus JW, Belkacemi Y, Petignat P, Schinagl DA, Coens C, Messina CG, Bogaerts J, Rutgers EJ. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 noninferiority trial. Lancet Oncol. 2014;15(12):1303-10. http://dx.doi.org/10.1016/ S1470-2045(14)70460-7. PMid:25439688.
3. Kafejian-Haddad AP, Garcia AP, Mitev AG, Reis A, Kassab C, Centofanti G, Barella SM, Kafejian O. Avaliação linfocintilográfica dos linfedemas dos membros inferiores: correlação com achados clínicos em 34 pacientes. J Vasc Bras. 2005;4(3):283-9. http://dx.doi.org/10.1590/S1677-54492005000300011.
4. Lawenda BD, Mondry TE, Johnstone PAS. Lymphedema: a primer on the identification and management of a chronic condition in oncologic treatment. CA Cancer J Clin. 2009;59(1):8-24. http://dx.doi.org/10.3322/caac.20001. PMid:19147865.
5. International Society of Lymphology. The diagnosis and treatment of peripheral lymphedema: consensus document of the International Society of Lymphology. Lymphology. 2003;36(2):84-91. PMid:12926833.
6. Dionyssiou D, Demiri E, Tsimponis A, Sarafis A, Mpalaris V, Tatsidou G, Arsos G. A randomized control study of treating secondary stage II breast cancer-related lymphoedema with free lymph node transfer. Breast Cancer Res Treat. 2016;156(1):73-9. http://dx.doi.org/10.1007/s10549-016-3716-0. PMid:26895326.
7. Becker C, Assouad J, Riquet M, Hidden G. Postmastectomy lymphedema: long-term results following microsurgical lymph node transplantation. Ann Surg. 2006;243(3):313-5. http://dx.doi.org/10.1097/01.sla.0000201258.10304.16. PMid:16495693.
8. Maldonado AA, Chen RU, Chang DW. The Use of supraclavicular free flap with vascularized lymph node transfer for treatment of lymphedema: a prospective study of 100 consecutive cases. J Surg Oncol. 2017;115(1):68-71. http://dx.doi. org/10.1002/jso.24351. PMid:27449974.
9. Ho OA, Lin CY, Pappalardo M, Cheng MH. Comparisons of submental and groin vascularized lymph node flaps transfer for breast cancer-related lymphedema. Plast Reconstr Surg Glob Open. 2018;6(12):e1923. http://dx.doi.org/10.1097/ GOX.0000000000001923. PMid:30656093.
10. Pedrosa BCS, Maia JN, Ferreira APL, Araújo MGR, Montenegro EJN, Silva FL, Castro CMMB, Andrade MA. Funcionalidade e qualidade de vida em indivíduos com linfedema unilateral em membro inferior: um estudo transversal. J Vasc Bras. 2019;18:e20180066. http://dx.doi.org/10.1590/1677-5449.006618. PMid:31320877.
11. Bergmann A, Mattos IE, Koifman RJ. Incidência e prevalência de linfedema após tratamento cirúrgico do câncer de mama: revisão de literatura. Rev Bras Cancerol. 2007;53(4):461-70. http://dx.doi.org/10.32635/2176-9745. RBC.2007v53n4.1788. Abreu et al. Arch Head Neck Surg. 2023;52:e20230021.
12. Cormier JN, Askew RL, Mungovan KS, Xing Y, Ross MI, Armer JM. Linfedema além do câncer de mama: uma revisão sistemática e meta-análise do linfedema secundário relacionado ao câncer. Cancer. 2010;116(22):5138. http://dx.doi. org/10.1002/cncr.25458. PMid:20665892.
13. Cheng MH, Huang JJ, Nguyen DH, Saint-Cyr M, Zenn MR, Tan BK, Lee CL. A novel approach to the treatment of lower extremity lymphedema by transferring a vascularized submental lymph node flap to the ankle. Gynecol Oncol. 2012;126(1):93-8. http://dx.doi.org/10.1016/j.ygyno.2012.04.017. PMid:22516659.
Submitted date:
07/05/2023
Accepted date:
09/24/2023
Facebook
Google+
Twitter
LinkedIn
Mendeley
StumbleUpon
CiteULike
Reddit
Email